Grapefruit, Medicine Interaction Warning Expanded
ABC News’ Ben Maas reports: It has long been known that grapefruit juice can pose dangerous — and even deadly — risks when taken along with certain medications. Now, experts warn the list of medications that can result in these interactions is longer than many...
FDA Faulted for Spotty Oversight of Data Coming from Overseas
WASHINGTON -- The U.S. Food and Drug Administration hasn't done enough to monitor clinical trial data coming from overseas sites and patients, which increasingly dominate the studies used to support drug applications in the United States, according to a report from the Department of Health and
FDA Warns of Fracture Risk with PPIs
Proton pump inhibitors (PPIs) may increase the risk of fractures of the hip, wrist, and spine with high-dose or chronic use, the U.S. Food and Drug Administration warned Tuesday. Labeling on drugs in this class -- both prescription and over-the-counter -- will change to reflect this risk, the
Bill Clinton Hospitalized for Routine Stent Surgery; Stress May Have Triggered Chest Pain
Former President, Known for '20-Hour Days for 20 Years,' Has Heart Surgery After Stressful Haiti Trip
New Anti-Clotting Drug Outperforms Plavix
WEDNESDAY, Jan. 13 (HealthDay News) -- A new clot-busting drug, Brilinta, may soon take the place of Plavix in treating patients with acute coronary syndrome, which includes angina and heart attack. In a new trial, the upstart drug, ticagrelor (Brilinta) reduced the risk of second heart attacks and
Blood Thinner Combos Risky for Heart Attack Patients
Bleeding risk highest for those taking both warfarin and clopidogrel, study finds.
New Blood Thinner Could Replace Warfarin to Fight Venous Clots
Dabigatran equals older anti-clotting drug, with fewer hassles, study finds
Advertising to Consumers May Raise Drug Prices
TUESDAY, Nov. 24 (HealthDay News) -- Direct-to-consumer drug ads may contribute to higher Medicaid costs, according to a new study that examined sales of the widely used antiplatelet drug clopidogrel (Plavix). The analysis of data from 1999 to 2005 for 27 state Medicaid programs found that
Plavix Ads Increase Medicaid Costs but not Usage
Medicaid spending on the clot-busting drug Plavix soared after direct-to-consumer TV ads for the drug began airing -- though not because of any change in prescription trends, researchers said. Plavix usage by Medicaid recipients stayed on the same upward track as before the ads started, but the
Newer Blood Thinners May Outperform Old Standbys
Studies found warfarin, Plavix bested by latest anti-clotting alternatives.